Premature babies do not require changes to the usual schedule to receive vaccines. Haemophilus influenzae tipe b(Hib) ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN ...

The shot protects against common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y), covering five of the six serogroups that cause most disease worldwide, with the B, C, and ...

The FDA has given a fast-track designation to a gonorrhoea vaccine in development at GSK that could help turn the tide of the sexually-transmitted infection, which is on the rise around the world ...

Pegcetacoplan has been approved for the treatment of C3 glomerulopathy or primary immune complex membranoproliferative ...

C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant C3G disease recurrence ...

Gonorrhea can affect people of any age, anatomy, or gender, but it's particularly common among teens and young adults between the ages of 15 and 24.